Icon

AEROSPAN HFA (nda021247)- (0.078MG/INH)

FLUNISOLIDE MYLAN SPECIALITY LP
0.078MG/INH
No No
2018-Jul-06 Expired
None None
None No
AEROSPAN is an inhaled corticosteroid indicated for • Maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. • Asthma patients requiring oral corticosteroid therapy, where adding AEROSPAN inhalation aerosol may reduce or eliminate the need for oral corticosteroids.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.078MG/INH ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.